NASDAQ · IBRX
ImmunityBio, Inc.
$8.74-$0.07 (-0.79%)
ImmunityBio, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.69% below the high.
Loading market information…
NYSE · ARDT · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ardent Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.49% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Ardent Health Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $0.23. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ardent Health Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 6, 2025 |
| $0.29+38.1% vs estimate |
| $1.50B-0.03% vs estimate |
| Q4 2024 | Feb 26, 2025 | $0.81+62.0% vs estimate | $1.61B+7.26% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | $0.17-43.33% vs estimate | $1.45B-0.18% vs estimate |
|---|
THE ANALYST VIEW
12 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 3 contributors · Median target $13.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$8.74-$0.07 (-0.79%)
ImmunityBio, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.69% below the high.
$13.64+$0.25 (+1.83%)
LifeStance Health Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$13.26+$0.20 (+1.53%)
Aveanna Healthcare Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.86% below the high.
$29.46-$0.05 (-0.17%)
Acadia Healthcare Company, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.78% below the high.
$10.27+$0.29 (+2.91%)
Brookdale Senior Living Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.91% below the high.
$29.18+$0.27 (+0.93%)
Pediatrix Medical Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.48% below the high.
$124.34+$2.16 (+1.77%)
Addus HomeCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
